Phenominer Database Results (26 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion number to liver volume ratio orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 16820.0 /cm3 5100.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal Add 67445 655
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion number to liver volume ratio N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 3840.0 /cm3 1450.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). 67437 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions as percentage of total liver volume N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 59.0 % 9.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days 67438 655
F344.BN-(D16Mit5-D16Rat75) ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 10.67 % 1.4 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal pcna index 68109 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions as percentage of total liver volume orchiectomy then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 19.0 % 5.4 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67446 655
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion number to liver volume ratio ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 7380.0 /cm3 920.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal Add 67457 655
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion number N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 38.6 null 12.06 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 224 days intraperitoneal per liver 67459 655
F344.BN-(D16Mit5-D16Rat75) ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 6.42 % 0.99 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal pcna index 68106 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions as percentage of total liver volume orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 33.0 % 8.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67442 655
F344.BN-(D16Mit5-D16Rat75) ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells orchiectomy then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 3.55 % 0.98 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal pcna index 68107 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions as percentage of total liver volume N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 10.0 % 4.1 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days 67450 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 3.9 cm3 x 10000 0.74 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67796 655
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion number to liver volume ratio orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 9420.0 /cm3 990.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). 67441 655
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion diameter measurement N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 4.19 mm 1.3 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 224 days intraperitoneal 67460 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions orchiectomy then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 0.18 cm3 x 10000 0.11 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67793 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 4.76 cm3 x 10000 0.4 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days 67791 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 0.47 cm3 x 10000 0.13 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67792 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 0.16 cm3 x 10000 0.09 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days 67794 655
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion number to liver volume ratio N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 11630.0 /cm3 890.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). 67449 655
F344.BN-(D16Mit5-D16Rat75) liver tumorous lesion number to liver volume ratio ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 12820.0 /cm3 2800.0 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). 67453 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions as percentage of total liver volume ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 69.0 % 9.8 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67458 655
F344.BN-(D16Mit5-D16Rat75) ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait male 0 days 0 12.14 % 1.45 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days pcna index 68105 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 0.39 cm3 x 10000 0.15 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67795 655
F344.BN-(D16Mit5-D16Rat75) volume of liver occupied by tumorous lesions as percentage of total liver volume ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 19.0 % 4.2 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal 67454 655
F344.BN-(D16Mit5-D16Rat75) ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells N-nitrosodiethylamine (200 mg/kg) (for 56 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 2.76 % 1.1 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days pcna index 68108 655
F344.BN-(D16Mit5-D16Rat75) ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. liver integrity trait female 0 days 0 15.33 % 0.74 ex vivo light microscopy with digital image analysis 0.0 N-nitrosodiethylamine injection at 200mg/kg 56 days intraperitoneal pcna index 68110 655